Latest Period
Q2 2026
Security Snapshot
AbbVie Inc. - Common Stock (ABBV) Institutional Ownership
CUSIP: 00287Y109
13F Institutional Holders and Ownership History from Q1 2014 to Q2 2026
Institutions Reporting
4,203
Shares (Excl. Options)
1,332,981,111
Price
$251.64
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- ABBV on NYSE
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 1,332,981,111
- Total 13F value
- $335,146,273,037
- Portfolio coverage rank
- 0.25%
- Share change
- +36,600,337
- Value change
- +$9,266,069,166
- Number of holders
- 4,203
- Shares outstanding
- 1,769,960,826
- SEC-reported price per share
- $256.91
- Insider filing price
- $256.91
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- ABBV - AbbVie Inc. - Common Stock is tracked under CUSIP 00287Y109.
- 4203 institutions reported positions in Q2 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 4,095 to 4,203 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $281,845,877,014 to $335,146,273,037.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 4203 institutions filings for Q2 2026.
Security key
00287Y109
Latest holder period
Q2 2026
13F holders
4,203
13D/G owners
1
CIK / CUSIP context first
Open Q2 2026 holders
ABBV full holder history
AbbVie Inc. SEC filings
AbbVie Inc. company facts
AbbVie Inc. insider transactions
AbbVie Inc. 13D/G history
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 00287Y109:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
ABBV
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 7.5% | $28,909,653,374 | 132,924,058 | Vanguard Capital Management | 31 Mar 2026 |
As of 30 Jun 2026, 4,203 institutional investors reported holding 1,332,981,111 shares of AbbVie Inc. - Common Stock (ABBV). This represents 75% of the company’s total 1,769,960,826 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
47%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 8.4% | 149,488,412 | -0.8% | 0.56% | $37,617,263,993 |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.5% | 115,396,098 | +0.45% | 0.62% | $29,038,274,101 |
| STATE STREET CORP | 4.7% | 82,596,748 | +1.7% | 0.62% | $20,784,645,667 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.7% | 48,477,996 | -2.1% | 0.55% | $12,199,002,913 |
| JPMORGAN CHASE & CO | 2.7% | 47,862,796 | -16% | 0.71% | $12,171,988,269 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.7% | 46,998,433 | +0.56% | 0.63% | $11,805,227,357 |
| MORGAN STANLEY | 2.2% | 38,901,001 | +2.3% | 0.52% | $9,789,048,614 |
| Capital Research Global Investors | 1.7% | 30,101,551 | -3.7% | 1.1% | $7,574,798,407 |
| NORGES BANK | 1.4% | 25,554,538 | 0.64% | $6,430,543,942 | |
| BANK OF AMERICA CORP /DE/ | 1.2% | 21,237,764 | -11% | 0.34% | $5,344,270,976 |
| FMR LLC | 1.2% | 20,773,786 | -4.5% | 0.23% | $5,227,515,471 |
| NORTHERN TRUST CORP | 1.2% | 20,558,447 | -3.1% | 0.6% | $5,173,327,604 |
| FRANKLIN RESOURCES INC | 1.1% | 19,925,232 | +37% | 1.1% | $5,013,985,356 |
| Capital World Investors | 1.1% | 19,178,966 | +21% | 0.57% | $4,826,436,854 |
| GOLDMAN SACHS GROUP INC | 0.92% | 16,291,630 | +7.6% | 0.43% | $4,099,625,714 |
| Capital International Investors | 0.88% | 15,638,631 | +8.5% | 0.81% | $3,936,357,038 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.83% | 14,749,069 | +13% | 0.37% | $3,711,457,000 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.81% | 14,267,697 | +0.75% | 0.65% | $3,590,323,274 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.73% | 12,914,230 | -0.41% | 0.43% | $3,250,509,754 |
| Bank of New York Mellon Corp | 0.73% | 12,853,368 | -3.2% | 0.53% | $3,234,421,677 |
| UBS Group AG | 0.73% | 12,845,120 | -8.6% | 0.51% | $3,232,345,996 |
| Legal & General Group Plc | 0.65% | 11,548,053 | -5% | 0.61% | $2,905,952,066 |
| AMERIPRISE FINANCIAL INC | 0.65% | 11,519,507 | +4.1% | 0.59% | $2,900,213,433 |
| DEUTSCHE BANK AG\ | 0.61% | 10,772,949 | +13% | 0.79% | $2,710,904,889 |
| RAYMOND JAMES FINANCIAL INC | 0.59% | 10,410,159 | +8.4% | 0.71% | $2,619,612,537 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
50
Latest
Q2 2026
Rows shown
1-25 of 50
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 1,332,981,111 | $335,146,273,037 | +$9,266,069,166 | $251.64 | 4,203 |
| 2026 Q1 | 1,297,469,096 | $281,845,877,014 | -$5,017,369,111 | $217.49 | 4,095 |
| 2025 Q4 | 1,317,975,937 | $300,943,385,952 | +$9,344,782,058 | $228.49 | 4,135 |
| 2025 Q3 | 1,270,015,568 | $293,795,490,662 | -$3,123,583,240 | $231.54 | 3,878 |
| 2025 Q2 | 1,287,075,518 | $238,891,433,790 | +$4,866,082,603 | $185.62 | 3,742 |
| 2025 Q1 | 1,261,493,107 | $264,023,235,689 | -$2,130,141,483 | $209.52 | 3,780 |
| 2024 Q4 | 1,275,092,654 | $226,558,537,921 | +$1,209,556,751 | $177.70 | 3,709 |
| 2024 Q3 | 1,263,246,128 | $249,268,364,641 | +$88,413,171 | $197.48 | 3,466 |
| 2024 Q2 | 1,262,725,926 | $216,474,972,193 | +$1,915,850,329 | $171.52 | 3,339 |
| 2024 Q1 | 1,253,088,393 | $227,875,219,935 | +$2,788,759,396 | $182.10 | 3,353 |
| 2023 Q4 | 1,239,748,668 | $192,192,568,041 | +$1,517,401,072 | $154.97 | 3,297 |
| 2023 Q3 | 1,228,903,942 | $183,197,476,249 | +$1,009,113,820 | $149.06 | 3,092 |
| 2023 Q2 | 1,221,315,614 | $164,787,374,519 | -$1,664,070,544 | $134.73 | 3,053 |
| 2023 Q1 | 1,233,425,991 | $196,519,460,228 | +$259,081,467 | $159.37 | 3,117 |
| 2022 Q4 | 1,235,502,434 | $199,621,628,438 | +$2,752,393,686 | $161.61 | 3,144 |
| 2022 Q3 | 1,221,220,466 | $164,097,646,774 | +$170,284,213 | $134.21 | 2,949 |
| 2022 Q2 | 1,217,745,031 | $186,477,353,594 | +$3,489,007,770 | $153.16 | 2,980 |
| 2022 Q1 | 1,203,308,144 | $195,040,563,504 | +$2,450,810,000 | $162.11 | 3,033 |
| 2021 Q4 | 1,188,323,728 | $160,862,723,207 | +$1,040,998,406 | $135.40 | 2,954 |
| 2021 Q3 | 1,177,170,536 | $127,005,644,713 | -$384,320,770 | $107.87 | 2,641 |
| 2021 Q2 | 1,182,050,895 | $133,115,260,852 | -$647,210,591 | $112.64 | 2,657 |
| 2021 Q1 | 1,186,224,948 | $128,344,178,557 | -$1,087,268,478 | $108.22 | 2,595 |
| 2020 Q4 | 1,197,885,694 | $128,301,295,744 | -$1,070,454,735 | $107.15 | 2,580 |
| 2020 Q3 | 1,210,244,308 | $105,941,681,033 | -$1,507,877,911 | $87.59 | 2,356 |
| 2020 Q2 | 1,226,149,387 | $120,286,919,217 | +$14,394,795,664 | $98.18 | 2,397 |